ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2024
Commentary: Liquid Biopsy for Average-Risk Colorectal Cancer Screening.
Article in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06929481 (Screening With Liquid Biopsies to Address Colorectal Cancer Inequities), which is not on this map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Screening With Liquid Biopsies to Address Colorectal Cancer Inequities
Who cites it
10 citing papers in PubMed.
- Blood-based cell-free DNA for addressing colorectal cancer screening disparities: a study protocol for a randomised trial.BMJ open · 2026Article
- The Centers for Medicare and Medicaid Services and others misunderstand stool testing for colorectal cancer.Journal of the National Cancer Institute · 2026Review
- Comparative benefits, burdens, and harms of emerging blood-based tests for colorectal cancer screening.Journal of the National Cancer Institute · 2026Article
- Beyond screening: neighborhood-level factors associated with colorectal cancer stage at diagnosis.Cancer causes & control : CCC · 2025Article
- Evaluating benefit-to-burden ratios of the established and emerging colorectal cancer screening strategies.Journal of the National Cancer Institute · 2025Article
- Detection of Early-Stage Colorectal Cancer Using Cell-Free oncRNA Biomarkers and Artificial Intelligence.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025Article
- Cancer Screening Progress and Noninvasive Screening Opportunities since the Onset of the COVID-19 Pandemic.Cancer prevention research (Philadelphia, Pa.) · 2025Article
- How Good Is Good Enough? What Should Be the Target for CRC Screening?Digestive diseases and sciences · 2025Review
- Estimated proportion of cancer deaths not addressed by current cancer screening efforts in the United States.Cancer biomarkers : section A of Disease markers · 2025Article
- Projected Impact and Cost-Effectiveness of Novel Molecular Blood-Based or Stool-Based Screening Tests for Colorectal Cancer.Annals of internal medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.